Abstract
A 2580-bp region of the chromosome of Streptomyces argillaceus, the producer of the antitumor polyketide mithramycin, was sequenced. Analysis of the nucleotide sequence revealed the presence of two genes (mtmGIII and mtmGIV) encoding proteins that showed a high degree of similarity to glycosyltransferases involved in the biosynthesis of various antibiotics and antitumor drugs. Independent insertional inactivation of both genes produced mutants that did not synthesize mithramycin but accumulated several mithramycin intermediates. Both mutants accumulated premithramycinone, a non-glycosylated intermediate in mithramycin biosynthesis. The mutant affected in the mtmGIII gene also accumulated premithramycin A1, which contains premithramycinone as the aglycon unit: and a D-olivose attached at C-12a-O. These experiments demonstrate that the glycosyltransferases MtmGIV and MtmGIII catalyze the first two glycosylation steps in mithramycin biosynthesis. A model is proposed for the glycosylation steps in mithramycin biosynthesis.
Original language | English |
---|---|
Pages (from-to) | 991-1000 |
Number of pages | 10 |
Journal | Molecular and General Genetics |
Volume | 262 |
Issue number | 6 |
DOIs | |
State | Published - 2000 |
Bibliographical note
Funding Information:Acknowledgments This work was supported by grants of the European Community to J.R. and J.A.S. (BIO4-CT96–0068) and from the Spanish Ministery of Education and Science to J.A.S. through the ``Plan Nacional en Biotecnologia'' (BIO97–0771), and the Medical University of South Carolina to J.R.
Keywords
- Antitumor
- Aureolic acid
- Polyketides
- Streptomycetes
ASJC Scopus subject areas
- Genetics